×

CellRapeutics™ CD56+ NK Cells from Scleroderma Donor (XS-0426-XU301)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Sourced from donors with Systemic Sclerosis, these CD56+ NK cells provide a unique window into the innate immune regulation of fibrosis. The cells are isolated to ensure maximum viability for functional assays focusing on NK-mediated inhibition of collagen synthesis or their direct cytotoxic effects on pathogenic myofibroblasts. This product is vital for understanding the transition from vascular injury to irreversible tissue scarring.

Specific Inquiry

  • Size:
  Add to Cart

Donor Information

  • Product Name
  • CellRapeutics™ CD56+ NK Cells from Scleroderma Donor
  • Cat. No.
  • XS-0426-XU301
  • Donor Age
  • Middle-Aged
  • Donor Health
  • NK cells exhibit a pro-fibrotic signaling profile. These cells show unique phenotypic shifts that reflect their interaction with activated fibroblasts and their contribution to the systemic vascular and fibrotic microenvironment.
  • Ethnicity
  • Diverse backgrounds available, predominantly African American and Hispanic cohorts.
  • Anticoagulant
  • Heparin or Acid Citrate Dextrose, optimized to maintain cellular flexibility and functional metabolic state, accounting for altered rheological properties in scleroderma peripheral blood.
  • Additional Donor Information
  • Each lot features CD56+ NK cells from donors with Systemic Sclerosis. Profiles emphasize limited vs. diffuse involvement to study the NK cell contribution to vascular injury and fibrosis.
  • Clinical Profile
  • Skin thickening score, autoantibody profile, presence of Raynaud's phenomenon, and systemic involvement.

Additional Information

  • Medication History
  • Available upon request. Includes history of systemic immunosuppressants and antifibrotic agents, with documentation of vascular therapies that may influence peripheral NK cell counts.
  • Formulation
  • Cryopreserved in specialized freezing medium
  • Cell Purity
  • >90%
  • Cell Viability
  • >90%
  • Mycoplasma Testing
  • Negative
  • Sterility Testing
  • Negative
  • Genetic Stability Testing
  • The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.
  • Application
  • Drug Discovery, Immuno-oncology Research
  • Research Use Only
  • RUO
  • Quality Control
  • Each product batch undergoes rigorous testing for purity, viability, and microbial contamination.
  • Storage
  • Maintain long-term storage in liquid nitrogen vapor phase (below -150°C), avoid temperature fluctuations above -135°C to preserve NK cell lytic activity.
  • Shiping
  • Dry Ice
  • Handling Notes
  • Perform rapid thawing at 37°C and implement slow, dropwise dilution with pre-warmed media to minimize osmotic stress and ensure optimal cell recovery.
  • Warnings
  • Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.
  • Size
  • 5E6 cells/vial, 1E7 cells/vial
  • Keywords
  • CellRapeutics™ CD56+ NK Cells from Scleroderma Donor, CD56+ NK Cells, Scleroderma

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ CD56+ NK Cells from Scleroderma Donor (XS-0426-XU301). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.